[Skip to Content]
[Skip to Content Landing]
Editorial
October 2014

Acid-Reducing Agents in Infants and Children: Friend or Foe?

Author Affiliations
  • 1Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
JAMA Pediatr. 2014;168(10):888-890. doi:10.1001/jamapediatrics.2014.1263

Gastroesophageal reflux disease (GERD) is common in infants and children and has been estimated to affect as much as 3.3% of the pediatric population.1 Despite this, we still struggle with the management of GERD. With a growing body of literature that illustrates a lack of efficacy and alarming adverse effects, there is increasing reason to limit the empirical use of acid suppression therapy in children.

×